Canada markets closed

OKYO Pharma Limited (OKYO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.1600-0.0500 (-4.13%)
At close: 04:00PM EDT
1.1700 +0.01 (+0.86%)
After hours: 07:32PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
6,338
6,338
1,610
348.347
518.098
Selling General and Administrative
-
-
-
1,219
-
Total Operating Expenses
13,187
13,187
6,218
3,366
1,535
Operating Income or Loss
-13,187
-13,187
-6,218
-3,366
-1,535
Interest Expense
96.687
96.687
0
1.123
1.158
Total Other Income/Expenses Net
-
-
-
-11.172
-132.668
Income Before Tax
-13,284
-13,284
-6,218
-3,379
-1,620
Income Tax Expense
-12.202
-12.202
-786.521
-24.994
-76.288
Income from Continuing Operations
-13,272
-13,272
-5,431
-3,354
-1,544
Net Income
-13,272
-13,272
-5,431
-3,354
-1,544
Net Income available to common shareholders
-13,272
-13,272
-5,431
-3,354
-1,544
Basic EPS
-0.61
-0.61
-0.36
-0.32
-0.00
Diluted EPS
-0.61
-0.61
-0.36
-0.32
-0.00
Basic Average Shares
22,257
22,257
15,065
10,350
595,474
Diluted Average Shares
22,257
22,257
798,259
10,350
595,474